ALECTOR INC. - COMMON STOCK

Alector to Participate in the BofA Securities 2023 Healthcare Conference

02 مايو 2023 07:00:00 بحسب Nasdaq GlobeNewswire

Alector to Participate in Upcoming Healthcare Conferences

01 مارس 2023 16:05:00 بحسب Nasdaq GlobeNewswire

Alector Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update

28 فبراير 2023 16:05:01 بحسب Nasdaq GlobeNewswire

Alector Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

08 ديسمبر 2022 16:30:00 بحسب Nasdaq GlobeNewswire

Alector Presents Results from First-in-Human Phase 1 Study of AL101 for the Treatment of Neurodegenerative Diseases

29 نوفمبر 2022 11:05:00 بحسب Nasdaq GlobeNewswire

Alector Reports Third Quarter 2022 Financial Results and Provides Business Update

08 نوفمبر 2022 16:05:01 بحسب Nasdaq GlobeNewswire

Alector to Participate in Upcoming Healthcare Conferences

07 نوفمبر 2022 07:00:01 بحسب Nasdaq GlobeNewswire

Alector Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

03 نوفمبر 2022 16:30:00 بحسب Nasdaq GlobeNewswire

Alector Announces Promotion of Clare Hunt to Chief People Officer

13 أكتوبر 2022 08:00:01 بحسب Nasdaq GlobeNewswire

Alector Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

06 أكتوبر 2022 16:30:00 بحسب Nasdaq GlobeNewswire

Alector Initiates Phase 1 Clinical Trial of AL044 for the Treatment of Alzheimer’s Disease (AD)

12 سبتمبر 2022 07:00:00 بحسب Nasdaq GlobeNewswire

Alector to Participate in Upcoming Healthcare Conferences

07 سبتمبر 2022 07:00:01 بحسب Nasdaq GlobeNewswire

Alector Reports Second Quarter 2022 Financial Results and Provides Business Update

04 أغسطس 2022 16:05:01 بحسب Nasdaq GlobeNewswire

Alector to Participate in the Goldman Sachs 43rd Annual Global Healthcare Conference

08 يونيو 2022 07:00:00 بحسب Nasdaq GlobeNewswire

Alector Reports Inducement Grants as permitted by the Nasdaq Listing Rules

27 مايو 2022 16:30:00 بحسب Nasdaq GlobeNewswire

Alector Reports First Quarter 2022 Financial Results and Provides Business Update

05 مايو 2022 16:05:02 بحسب Nasdaq GlobeNewswire

Alector to Participate at the BofA Securities 2022 Healthcare Conference

04 مايو 2022 07:00:01 بحسب Nasdaq GlobeNewswire

Alector Announces Appointment of Gary Romano, M.D., Ph.D., as Chief Medical Officer

29 مارس 2022 16:05:00 بحسب Nasdaq GlobeNewswire

Alector Presents AL001 (latozinemab) Data from the FTD-C9orf72 Cohort of the INFRONT-2 Phase 2 Clinical Trial

15 مارس 2022 08:00:01 بحسب Nasdaq GlobeNewswire

Alector to Present at Upcoming Healthcare Conferences

09 مارس 2022 07:00:01 بحسب Nasdaq GlobeNewswire